JP2022529823A5 - - Google Patents
Info
- Publication number
- JP2022529823A5 JP2022529823A5 JP2021562906A JP2021562906A JP2022529823A5 JP 2022529823 A5 JP2022529823 A5 JP 2022529823A5 JP 2021562906 A JP2021562906 A JP 2021562906A JP 2021562906 A JP2021562906 A JP 2021562906A JP 2022529823 A5 JP2022529823 A5 JP 2022529823A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- note
- composition according
- sodium
- chloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962836858P | 2019-04-22 | 2019-04-22 | |
| US62/836,858 | 2019-04-22 | ||
| PCT/US2020/029168 WO2020219475A1 (en) | 2019-04-22 | 2020-04-21 | Compositions and methods useable for treatment of dry eye |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022529823A JP2022529823A (ja) | 2022-06-24 |
| JP2022529823A5 true JP2022529823A5 (https=) | 2023-05-10 |
Family
ID=72941233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562906A Pending JP2022529823A (ja) | 2019-04-22 | 2020-04-21 | ドライアイの治療に使用可能な組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20200345805A1 (https=) |
| EP (1) | EP3958915A4 (https=) |
| JP (1) | JP2022529823A (https=) |
| KR (1) | KR20220003548A (https=) |
| CN (1) | CN114040783A (https=) |
| CA (1) | CA3134362A1 (https=) |
| IL (1) | IL287441A (https=) |
| MX (1) | MX2021012857A (https=) |
| WO (1) | WO2020219475A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX346362B (es) * | 2009-11-10 | 2017-03-15 | Allegro Pharmaceuticals Inc * | Composiciones y metodos para inhibir la adhesion celular o dirigir agentes de diagnostico o terapeuticos a sitios de enlace rgd. |
| US12454549B2 (en) | 2017-06-19 | 2025-10-28 | Jenius Pharma, Llc | Treatments for diseases and disorders that involve oxidative stress |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3128203B2 (ja) * | 1997-02-10 | 2001-01-29 | 一男 坪田 | 分泌腺細胞とリンパ球との接着阻害剤 |
| JP2000336030A (ja) * | 1999-03-24 | 2000-12-05 | Taisho Pharmaceut Co Ltd | 点眼液 |
| US20070104798A1 (en) * | 1999-10-04 | 2007-05-10 | S.K. Pharmaceuticals, Inc. | Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide |
| JP4255656B2 (ja) * | 2001-09-17 | 2009-04-15 | 株式会社メニコン | 眼科用液剤及びコンタクトレンズ用液剤 |
| US7351739B2 (en) * | 2004-04-30 | 2008-04-01 | Wellgen, Inc. | Bioactive compounds and methods of uses thereof |
| DK2444079T3 (en) * | 2005-05-17 | 2017-01-30 | Sarcode Bioscience Inc | Compositions and Methods for the Treatment of Eye Diseases |
| US10842669B2 (en) * | 2008-11-13 | 2020-11-24 | Gholam A. Peyman | Ophthalmic drug delivery method |
| ITRM20090102U1 (it) * | 2009-06-15 | 2010-12-16 | Alfa Intes Ind Terapeutica Splendore S R L | Ialuvit preparato per la stabilizzazione del film lacrimale, la cicatrizzazione corneale e il ripristino del contenuto salino della lacrima e osmoprotezione. |
| MX346362B (es) * | 2009-11-10 | 2017-03-15 | Allegro Pharmaceuticals Inc * | Composiciones y metodos para inhibir la adhesion celular o dirigir agentes de diagnostico o terapeuticos a sitios de enlace rgd. |
| WO2011106697A1 (en) * | 2010-02-25 | 2011-09-01 | Schepens Eye Research Institute | Therapeutic compositions for the treatment of dry eye disease |
| CA2849192C (en) * | 2011-10-12 | 2019-09-24 | Ascendis Pharma Ophthalmology Division A/S | Prevention and treatment of ocular conditions |
| TWI700085B (zh) * | 2015-06-22 | 2020-08-01 | 新源生物科技股份有限公司 | 酪胺酸激酶抑制劑之眼用調配物的用途 |
| US11433260B2 (en) * | 2015-12-21 | 2022-09-06 | Gholam A. Peyman | Cancer treatment methods using thermotherapy and/or enhanced immunotherapy |
| PT3266446T (pt) * | 2016-07-07 | 2019-01-30 | Salvat Lab Sa | Composição oftálmica compreendendo óleo de rícino e triglicérido de cadeia média |
| EP4389216A3 (en) * | 2017-06-19 | 2024-11-06 | Allegro Pharmaceuticals, LLC | Peptide compositions and therapeutic uses |
-
2020
- 2020-04-21 EP EP20794179.0A patent/EP3958915A4/en active Pending
- 2020-04-21 US US16/854,818 patent/US20200345805A1/en not_active Abandoned
- 2020-04-21 MX MX2021012857A patent/MX2021012857A/es unknown
- 2020-04-21 WO PCT/US2020/029168 patent/WO2020219475A1/en not_active Ceased
- 2020-04-21 KR KR1020217037228A patent/KR20220003548A/ko active Pending
- 2020-04-21 CN CN202080029842.3A patent/CN114040783A/zh active Pending
- 2020-04-21 CA CA3134362A patent/CA3134362A1/en active Pending
- 2020-04-21 JP JP2021562906A patent/JP2022529823A/ja active Pending
-
2021
- 2021-10-20 IL IL287441A patent/IL287441A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022062045A5 (https=) | ||
| FI82605B (fi) | Foerfarande foer framstaellning av encellskikt och vaevnader skyddande kondroitinsulfat-natriumhyaluronat -komposition. | |
| JP2022529823A5 (https=) | ||
| JP5956735B2 (ja) | Ｐ２ｙ２受容体作動薬およびヒアルロン酸またはその塩を組み合わせたことを特徴とするドライアイ治療剤 | |
| Wais‐Steider et al. | Effect of vanadate on gill cilia: switching mechanism in ciliary beat | |
| WO2007103111A8 (en) | Antiviral drugs for treatment of arenavirus infection | |
| NO20056239L (no) | Hyaluronsyre nanopartikler | |
| BR9813879A (pt) | Variante de protease, dna, vetor de expressão, célula hospedeira, composição de limpeza, alimento animal, composição para tratar um tecido, e, processo de produzir uma variante de protease | |
| JP2017002035A5 (https=) | ||
| RU2015132974A (ru) | Слезозаменитель, содержащий гиалуронат натрия и карбоксиметилцеллюлозу | |
| RU2013129222A (ru) | Глазные композиции, содержащие мукоадгезивные полисахариды, способные стимулировать восстановление эпителия роговицы | |
| JP3748970B2 (ja) | ヒアルロン酸ナトリウム含有水溶液 | |
| JP2009538287A5 (ja) | 低粘度グリコサミノグリカンで構成される組成物及び該組成物の間質性膀胱炎の治療での使用 | |
| BR112023017725A2 (pt) | Solução de tratamento de lentes de contato sem conservantes | |
| HU190687B (en) | Process for preparing new antithrombotic of polysaccharide base further pharmaceutical compositions containing such substance as active material | |
| JP4773721B2 (ja) | 第四級化アンモニウムシクロデキストリン化合物 | |
| JP2024512121A5 (https=) | ||
| US3663690A (en) | Mucolytic composition and method of treatment of broncho-pulmonary disorders therewith | |
| EP0895474A1 (en) | Liquid eye drop composition | |
| RU2021133821A (ru) | Композиции и способы, применимые для лечения синдрома сухого глаза | |
| JP2020524138A (ja) | 緑内障治療用点眼組成物 | |
| WO1997041864A1 (en) | Ophthalmic preparations | |
| EP1417970B1 (en) | Anti-allergic, anti-bacteric and anti-redden compound for eyes | |
| RU2013149171A (ru) | Глазные препараты на основе расар (гипофизарный активирующий аденилатциклазу полипептид), который восстанавливает нормальную зрительную функцию при ранней глаукоме | |
| JP2022180452A5 (https=) |